Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Future Microbiology|December 22, 2009
Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapyChris L McGowin, Richard B Pyles
Journal of Virology|September 29, 2006
Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infectionMelissa M Herbst-Kralovetz, Richard B Pyles
International Journal of Antimicrobial Agents|July 16, 2008
An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2)William A Rose, Cynthia Tuthill, Richard B Pyles
Current Microbiology|October 12, 2013
Quantification of bacterial uropathogens in preclinical samples using real-time PCR assaysJanet L Enderle, Aaron L Miller, Richard B Pyles
Diagnostic Microbiology and Infectious Disease|April 7, 2009
High-throughput multistrain polymerase chain reaction quantification of Chlamydia trachomatis from clinical and preclinical urogenital specimensChris L McGowin, Gregory C Whitlock, Richard B Pyles
Virology Journal|November 12, 2009
FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infectionWilliam A Rose, Chris L McGowin, Richard B Pyles
Infection and Immunity|December 10, 2009
Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculationChris L McGowin, Rae Ann Spagnuolo, Richard B Pyles
Infection and Immunity|February 4, 2010
Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infectionRichard B Pyles, G Eric Jezek, Tonyia D Eaves-Pyles
Pageof 8